On 10 Sep 2015
At this year’s ESCP meeting in Dublin, Ireland, Professor Andrea Coratti (Chief, Division of Oncological and Robotic General Surgery, Professor at General Surgery School, University of Florence and the University of Siena, Italy), will outline in his Keynote Lecture the role of robotics in colorectal surgery and assess whether it is time for the technology to be more widely adopted in Europe…
On 2 Sep 2015
At this year’s ESCP meeting in Dublin, Ireland, Professor Charles Knowles (Professor of Surgical Research at Queen Mary University of London and Consultant Colorectal Surgeon at Barts Health NHS Trust, London, UK), will assess the role of sacral nerve stimulation (SNS) for bowel disorders in one of several keynote presentations. In this interview, Professor Knowles discusses the benefits, limitations and evidence supporting its use…
On 14 Aug 2015
In a series of interviews, we will be previewing this year’s 10th ESCP Annual Meeting in Dublin, Ireland, 23-25 September 2015. We talked to Professor Dion Morton, who highlights the clinical trials under discussion at the research sessions in Dublin…On 18 Mar 2015
In April this year, the first regional educational masterclass organised by the ESCP in cooperation with the European Crohn's and Colitis Organisation (ECCO), will take place in Moscow, Russia. This inaugural masterclass will concentrate on Ulcerative Colitis (UC) and Crohn's disease (CD) and here keynote speaker, Professor Igor Khalif (State Scientific Centre for Coloproctology, Moscow, Russia), examines the role of medical therapy in treating Crohn's disease.
On 11 Mar 2015
Ahead of the first ESCP/ECCO regional masterclass in Moscow, Professor Yves Panis (Professor of Digestive Surgery at the Université Paris VII and Head of the Department of Colorectal Surgery at Beaujon Hospital, Clichy, France) discusses the surgical treatment of acute severe colitis. Although there are no established national registries or surveys on the exact numbers regarding the prevalence of acute severe colitis, the current evidence suggests that around 10-15% of all the patients with ulcerative colitis will at some point develop acute severe colitis. Although which patients will develop the condition and why, is unknown.ESCP Secretariat
c/o MCI UK Ltd
Unit 24/22 South
Building 4000, Langstone Park
Langstone Road
Havant PO9 1SA
01730 715 208
